Straumann Holding AG (OTCMKTS:SAUHY – Get Free Report) was the recipient of a large increase in short interest in the month of May. As of May 15th, there was short interest totaling 205,953 shares, an increase of 329.5% from the April 30th total of 47,951 shares. Based on an average daily volume of 225,996 shares, the days-to-cover ratio is presently 0.9 days. Currently, 0.0% of the shares of the company are sold short.
Analyst Ratings Changes
Several analysts recently weighed in on the company. Citigroup restated a “sell” rating on shares of Straumann in a research note on Thursday, April 23rd. Morgan Stanley reiterated an “underweight” rating on shares of Straumann in a research report on Tuesday, April 14th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and two have given a Sell rating to the company. According to MarketBeat, the stock presently has an average rating of “Reduce”.
Read Our Latest Stock Analysis on SAUHY
Straumann Trading Down 1.0%
Straumann Company Profile
Straumann (OTCMKTS:SAUHY) is a Swiss-based dental technology company that develops, manufactures and markets restorative, regenerative and digital solutions for dental professionals. The company’s core offerings center on implant-supported restorations and components, biomaterials used for bone and soft-tissue regeneration, and a range of prosthetic products used by dentists and dental laboratories to restore oral function and aesthetics.
In addition to implant and biomaterial product lines, Straumann provides digital dentistry solutions that support treatment planning and workflows.
Read More
- Five stocks we like better than Straumann
- 3 Stocks Rallying on Micron’s Price Boost: Substance or Hype?
- Snowflake and the Snowballing Impact of its AI Flywheel
- AI’s Biggest Bottleneck Could Make These 2 Stocks Soar
- These 3 Beaten-Down Stocks Just Saw $25 Million in Insider Buying
Receive News & Ratings for Straumann Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Straumann and related companies with MarketBeat.com's FREE daily email newsletter.
